drugset / Trial / NCT04168346

Preoperative Intravenous Iron Therapy in Patients With Gastric Cancer

NCT04168346

Phase 4 Not yet recruiting 202 enrolled Helsinki University Central Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The main objective of this investigator initiated study is to study if preoperative intravenous iron is effective in reducing need for allogenic blood transfusion in patients with gastric cancer who will undergo a standardized gastrectomy including both total and subtotal gastrectomies. The hypothesis is that intravenous iron reduces the need for perioperative blood transfusions.

Timeline

Start
2019-11
Primary completion
2021-11
Completion
2026-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Ferric carboxymaltose Other / unclassified 20 mg/kg Intravenous
Subject Ferric carboxymaltose Other / unclassified 1000 mg Intravenous